![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LXEO market cap is 490.56M. The company's latest EPS is USD -2.0153 and P/E is -7.39.
Quarter End | Dec 2023 | Mar 2024 | |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | |
Operating Income | -14.97M | -23.29M | |
Net Income | -14.19M | -21.68M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.66M | 654k | 0 |
Operating Income | -50.64M | -60.51M | -68.51M |
Net Income | -50.62M | -59.28M | -66.39M |
Quarter End | Dec 2023 | Mar 2024 | |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 139.81M | 213.21M | |
Total Liabilities | 26.27M | 30.26M | |
Total Equity | 113.54M | 182.95M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 136.86M | 97.08M | 139.81M |
Total Liabilities | 7.45M | 25M | 26.27M |
Total Equity | -55.6M | -112.95M | 113.54M |
Market Cap | 490.56M |
Price to Earnings Ratio | -7.39 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.04 |
Price to Book Ratio | 4.32 |
Dividend Yield | - |
Shares Outstanding | 32.95M |
Average Volume (1 week) | 236.02k |
Average Volume (1 Month) | 225.4k |
52 Week Change | 56.74% |
52 Week High | 22.33 |
52 Week Low | 9.00 |
Spread (Intraday) | 3.51 (21.26%) |
Company Name | Lexeo Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.lexeotx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions